<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00149175</url>
  </required_header>
  <id_info>
    <org_study_id>02-156</org_study_id>
    <secondary_id>02-346A10</secondary_id>
    <nct_id>NCT00149175</nct_id>
  </id_info>
  <brief_title>Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment</brief_title>
  <official_title>Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aventis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <brief_summary>
    <textblock>
      Patients with different types of dementia will be recruited and evaluated in national
      hospital departments for their usual neurological follow-ups. A blood sample will be proposed
      in the field of this research project, and the biological material will be stored at the DNA
      and Cell Bank of Institut de Fédératif Recherche (IFR) of Neurosciences (Pitié-Salpêtrière
      Hospital, Paris). The clinical research network is already set up for Alzheimer's disease and
      frontotemporal dementias, which permits an evaluation according to a clinical standardized
      protocol.

      Among these disorders, a monogenic sub-group has been identified. In Alzheimer's disease, it
      is associated with the APP, PSEN1 and PSEN2 genes, which account only for 75% of the familial
      forms with early onset. In frontotemporal dementias, the tau gene mutations account only for
      10% of the cases with an autosomal dominant inheritance. The identification of familial forms
      with a genetic inquiry in the relatives is essential for a greater knowledge of the molecular
      bases of forms not caused by the known genes, using linkage approaches and candidate gene
      analysis. The familial forms are also useful for identifying the modifier genes.

      In the multifactorial forms, the aim is to assemble a wide cohort of patients and controls
      matched for localizing and identifying susceptibility genetic factors. The strategies will
      use a candidate gene approach, and in the near future, studies of single nucleotide
      polymorphisms (SNPs) spread out in the whole genome. Meanwhile, similar approaches,
      particularly with candidate genes, could be used for identifying predictive factors of
      tolerance and response to the treatment.

      Finally, correlations will be performed with seric markers according to each kind of
      dementia.

      Specialized clinical teams in diagnosis and follow-up in dementias are assembled for this
      project, and in the study of neurological disorders of genetic origin.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2002</start_date>
  <completion_date type="Anticipated">October 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Alzheimer's Disease</condition>
  <condition>Dementia</condition>
  <condition>Neurodegenerative Disorders</condition>
  <arm_group>
    <arm_group_label>Neurodegenerative disorders with cognitive impairment</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>At risk reactive</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling, skin biopsy</intervention_name>
    <description>Blood sampling, skin biopsy in the field of the medical follow-up</description>
    <arm_group_label>Neurodegenerative disorders with cognitive impairment</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>At risk reactive</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Patients presenting with a neurodegenerative disorder

          -  At risk patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting with a neurodegenerative disorder with cognitive impairment
             controls (without signs of the disease), matched with sex and age with the patients

          -  Relatives for the familial cases

        Exclusion Criteria:

          -  Pregnant women

          -  Minors

          -  Persons refusing to sign the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis Brice, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris, University Paris 6</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexis Brice, MD</last_name>
    <phone>0033142162182</phone>
    <email>brice@ccr.jussieu.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de la Côte de Nacre</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles Defer, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Gilles Defer, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle Le Ber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Sainte-Marguerite</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard-François Michel, MD</last_name>
      <phone>0033491744949</phone>
      <email>bmichel@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Bernard-François Michel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Guillaume et René Laennec</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martine Vercelletto, MD</last_name>
      <phone>0033240165422</phone>
      <email>mvercelletto@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Martine Vercelletto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de l'Archet</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claude Desnuelle, MD, PhD</last_name>
      <phone>0033492035505</phone>
      <email>desnuelle.c@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Claude Desnuelle, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Hélène Soriani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pitié-Salpêtrière Hospital - Centre du Langage et de Neuropsychologie</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Dubois, MD</last_name>
      <phone>0033142161777</phone>
      <email>b.dubois@psl.ap-hop-paris.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno Dubois, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pitié-Salpêtrière Hospital - Fédération de Neurologie</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Meininger, MD, PhD</last_name>
      <email>vincent.meininger@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Meininger, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucette Lacomblez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François Salachas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pitié-Salpêtrière Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Brice, MD</last_name>
      <phone>0033142162182</phone>
      <email>brice@ccr.jussieu.fr</email>
    </contact>
    <investigator>
      <last_name>Alexis Brice, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle Le Ber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge Belliard, MD</last_name>
      <phone>0033299284293</phone>
      <email>belliard.s@voila.fr</email>
    </contact>
    <investigator>
      <last_name>Serge Belliard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique Golfier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Hannequin, MD, PhD</last_name>
      <phone>0033232888170</phone>
      <email>Didier.hannequin@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Didier Hannequin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Saint-Brieuc</city>
        <zip>22000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique Golfier, MD</last_name>
      <phone>0033296017454</phone>
      <email>veronique.golfier@ch-stbrieuc.fr</email>
    </contact>
    <investigator>
      <last_name>Véronique Golfier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bellevue</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Thomas-Antérion, MD</last_name>
      <phone>0033477127805</phone>
      <email>catherine.thomas@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine Thomas-Antérion, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Sellal, MD</last_name>
      <phone>0033388116892</phone>
      <email>Francois.Sellal@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>François Sellal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.inserm.fr</url>
  </link>
  <results_reference>
    <citation>Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, Thomas-Anterion C, Decousus M, Hannequin D, Véra P, Lacomblez L, Camuzat A, Didic M, Puel M, Lotterie JA, Golfier V, Bernard AM, Vercelletto M, Magne C, Sellal F, Namer I, Michel BF, Pasquier J, Salachas F, Bochet J; French research network on FTD/FTD-MND, Brice A, Habert MO, Dubois B. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain. 2006 Nov;129(Pt 11):3051-65.</citation>
    <PMID>17071924</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, Camuzat A, Brouwers N, Vandenberghe R, Sleegers K, Hannequin D, Dermaut B, Schymkowitz J, Campion D, Santens P, Martin JJ, Lacomblez L, De Pooter T, Peeters K, Mattheijssens M, Vercelletto M, Van den Broeck M, Cruts M, De Deyn PP, Rousseau F, Brice A, Van Broeckhoven C. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat. 2007 Apr;28(4):416.</citation>
    <PMID>17345602</PMID>
  </results_reference>
  <results_reference>
    <citation>Baba Y, Baker MC, Le Ber I, Brice A, Maeck L, Kohlhase J, Yasuda M, Stoppe G, Bugiani O, Sperfeld AD, Tsuboi Y, Uitti RJ, Farrer MJ, Ghetti B, Hutton ML, Wszolek ZK. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. J Neural Transm (Vienna). 2007 Jul;114(7):947-50. Epub 2007 Feb 23.</citation>
    <PMID>17318302</PMID>
  </results_reference>
  <results_reference>
    <citation>Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, Laquerrière A, De Pooter T, Camuzat A, Van den Broeck M, Dubois B, Sellal F, Lacomblez L, Vercelletto M, Thomas-Antérion C, Michel BF, Golfier V, Didic M, Salachas F, Duyckaerts C, Cruts M, Verpillat P, Van Broeckhoven C, Brice A; French Research Network on FTD/FTD-MND. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat. 2007 Sep;28(9):846-55.</citation>
    <PMID>17436289</PMID>
  </results_reference>
  <results_reference>
    <citation>Guedj E, Le Ber I, Lacomblez L, Dubois B, Verpillat P, Didic M, Salachas F, Vera P, Hannequin D, Lotterie JA, Puel M, Decousus M, Thomas-Antérion C, Magne C, Vercelletto M, Bernard AM, Golfier V, Pasquier J, Michel BF, Namer I, Sellal F, Bochet J, Volteau M, Brice A, Meininger V; French Research Network on FTD/FTD-MND, Habert MO. Brain spect perfusion of frontotemporal dementia associated with motor neuron disease. Neurology. 2007 Jul 31;69(5):488-90.</citation>
    <PMID>17664410</PMID>
  </results_reference>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>March 12, 2010</last_update_submitted>
  <last_update_submitted_qc>March 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Alexis Brice</name_title>
    <organization>Institut National de la Santé Et de la Recherche Médicale, France</organization>
  </responsible_party>
  <keyword>Alzheimer's disease</keyword>
  <keyword>Dementia</keyword>
  <keyword>Phenotype-genotype correlations</keyword>
  <keyword>Candidate genes</keyword>
  <keyword>Related disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Neurodegenerative Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

